Clinic letters become Portfolio Pathway evidence when they are selected for clinical complexity, properly anonymised, and paired with a short annotation that maps the decision-making in the letter to the relevant GMC domain and CiP. Volume does not matter. Ten well-chosen, annotated letters outperform fifty unannotated ones in any assessor's inbox.
Why clinic letters matter as evidence
The GMC's four-domain framework asks applicants to demonstrate Knowledge, Skills and Performance; Safety and Quality; Communication, Partnership and Teamwork; and Maintaining Trust. In practice, workplace-based assessments (Mini-CEX, CbD, DOPS) are the most direct route to the first two domains, but they are time-bound and supervisor-dependent. Clinic letters, by contrast, are generated continuously in the ordinary course of practice and capture a type of evidence that WBAs rarely reach: the texture of your actual clinical thinking, written at the time of the clinical encounter, to a clinical audience who expects accuracy.
For outpatient-heavy specialties, clinic correspondence is often the most authentic window into practice at consultant level. A rheumatology outpatient letter describing a complex biologics decision, a neurology letter working through the differential diagnosis of an atypical presentation, a geriatrics letter coordinating a complex discharge from an MDT perspective - these documents show decision-making in a way that a WBA form, completed retrospectively by a colleague who may not have been in the room, cannot fully replicate.
The Specialty Specific Guidance (SSG) for most outpatient-facing specialties explicitly references clinical correspondence as a relevant evidence type, though the language varies. Some SSGs refer to "clinic letters" directly; others refer to "clinical documentation" or "case documentation". In every case, the underlying principle is the same: assessors want to see what your clinical output looks like, not just what a supervisor said about you after watching you work.
Clinic letters are not a substitute for WBAs - they sit alongside them. Most specialties require a minimum number of WBAs as part of the evidence base. Letters supplement WBA evidence by showing the documentary output of the same clinical encounters, and by demonstrating consistent quality across a much larger sample of cases than a WBA portfolio alone can cover.
It is worth being precise about what counts as a "clinic letter" for these purposes. The broadest useful definition is: any correspondence generated from a clinical encounter that you led or significantly contributed to, directed to a GP, specialist colleague, patient, or relevant third party, that documents clinical reasoning and management decisions. This includes:
- New referral letters from outpatient or ambulatory care clinics
- Review appointment letters updating the GP on progress, investigation results, or management changes
- Discharge summaries from outpatient procedures where you had a consultant-level decision-making role
- Letters documenting shared decision-making conversations, including conversations about risks and alternatives
- Correspondence documenting capacity assessments, advance care planning discussions, or safeguarding concerns
- Letters coordinating care across MDT boundaries, including letters to MDT members or to specialist teams requesting input
What does not count: internal proforma-style notes with no narrative clinical reasoning; clerking documents where you were the junior on the team; letters dictated but substantially structured and written by a trainee under your supervision (though these can be referenced if you can document your supervising role).
GMC domain mapping for clinic letters
One of the most useful things you can do before selecting letters for submission is to map your candidate pool against the four GMC domains. Not because every letter must cover all four - they will not and need not - but because a portfolio that only demonstrates two domains through correspondence leaves the others underserved, and assessors will notice.
Clinic letters across the four GMC domains
Evidence mapping- Diagnostic reasoning and differential thinking visible in letter
- Investigation selection with clinical rationale
- Management decisions referenced to current guidelines
- Drug choices with dosing rationale documented
- Response to investigation results with clinical interpretation
- Case complexity that reflects consultant-level caseload
- Safety-netting instructions documented for GP
- Red-flag symptoms listed with action plan
- Drug monitoring requirements specified
- Escalation pathway clearly described
- Medication interactions or contraindications flagged
- Follow-up timing linked to clinical risk
- Plain-language explanation of diagnosis to patient
- Shared decision-making conversation documented
- MDT coordination and cross-specialty liaison
- Patient understanding confirmed in the letter
- Named contacts and responsibilities clearly assigned
- Interpreter use or communication adjustments noted
- Consent conversations documented with patient's expressed wishes
- Capacity assessment where relevant
- Advance care planning documented
- Safeguarding concerns and actions taken
- Handling of patient refusal with respect documented
- Honest acknowledgement of clinical uncertainty
In practice, most clinic letters contribute most strongly to Domain 1 and Domain 3. Domain 2 content appears naturally in letters where safety-netting is explicit. Domain 4 content is rarer but highly valued - a letter documenting a consent conversation, a capacity assessment, or the management of a patient who declined recommended treatment represents the kind of professional judgement that assessors find genuinely difficult to evidence through other documentation types.
If your candidate letter pool is weak on Domain 2 and Domain 4, that is useful diagnostic information before you submit. You may have the evidence in letters you have not yet reviewed, or you may need to generate new correspondence more deliberately. Some senior doctors never explicitly document safety-netting in clinic letters because they do it verbally; this is the moment to reconsider that habit, both for portfolio purposes and for clinical governance reasons.
What makes a letter evidence-quality
The single most important factor is whether the letter shows your clinical thinking, not just your clinical actions. An assessor reading a bare clinic letter cannot see why you chose one investigation over another, why you changed the management plan, why you decided to discharge rather than continue follow-up, or why you involved the MDT. If the letter only documents what happened - "investigations were arranged, patient was reviewed, plan was changed to X" - it shows that clinical activity occurred, not that it was driven by consultant-level reasoning.
Letters written with a referring GP audience in mind often do this naturally. A well-written GP letter explains the working diagnosis and why the obvious differential was rejected; it names the monitoring requirement and why it is at that frequency; it states the follow-up interval and what you are looking for at that point. This is good clinical communication. It is also, when selected and annotated well, excellent Portfolio Pathway evidence.
The five characteristics that distinguish an evidence-quality letter from a routine one:
Explicit clinical reasoning
The letter states, at least briefly, why you reached the conclusion you did. "The clinical picture is consistent with X rather than Y, given the absence of Z" is more evidential than "the patient has been diagnosed with X". The reasoning need not be exhaustive - this is a GP letter, not a case report - but it must be present.
Decision points that reflect consultant-level judgement
The letter documents a moment where you made a substantive clinical decision that a junior doctor could not or would not have made independently. This might be initiating a complex medication, deciding not to investigate further when investigation was clinically tempting but not warranted, or deciding on a treatment that required weighing competing risks. Generic clinic activity does not demonstrate this.
Patient context that shows caseload breadth
The case should be part of a portfolio that collectively demonstrates range: different diagnostic categories, different patient demographics, different degrees of complexity. A letter about a straightforward condition managed to guideline is not strong evidence in isolation but contributes to a picture of consistent, guideline-compliant practice when it sits alongside letters about complex cases.
Prospective documentation, not retrospective summary
Letters written at the time of the clinical encounter carry more evidential weight than summaries produced after the fact. The most authentic evidence is the letter you wrote to the GP on the day of the clinic, not a document you produced months later for portfolio purposes. Do not rewrite letters retrospectively to make them look better for the portfolio - this would be misleading and is unnecessary if you select well.
Falls within the five-year window
The five-year rule applies to clinical correspondence in the same way it applies to WBAs. Letters from outside the window carry limited weight. If your current post generates few clinic letters, this is the moment to generate new ones - either by requesting that your correspondence include more explicit clinical detail, or by writing patient-addressed letters where your practice only routinely produces GP letters.
Bare letter vs annotated entry: why the annotation changes everything
The single most common reason clinic letter evidence fails to land with assessors is the absence of annotation. A bare clinic letter submitted as a portfolio exhibit tells the assessor: "something clinical happened." An annotated letter entry tells the assessor: "here is what happened, here is the decision this represents, here is the domain it maps to, here is what this tells you about how I practise at consultant level."
- Letter submitted as a single PDF with no covering note
- No explanation of why this case was selected
- No identification of which domain the letter is intended to evidence
- No mapping to a specific CiP in the SSG
- Assessor has to read the full letter and infer its evidential purpose
- Clinical context is not explained - assessor may not know if the management was appropriate
- No link to other evidence about the same domain or CiP
- Fifty similar letters look like bulk submission rather than curated evidence
- Letter accompanied by a 200-300 word annotation at the top
- Annotation explains why this case was selected and what it demonstrates
- Explicit domain mapping: "this letter primarily evidences Domain 1 CiP X"
- Key decision highlighted: "the critical clinical judgement was..."
- Outcome noted where available: "at follow-up three months later, the patient..."
- Cross-reference to any paired WBA or reflective entry about the same case
- Ten annotated letters form a coherent, navigable evidence set
- Assessor can evaluate quickly and credit precisely
The annotation is not padding. It is the interpretive layer that turns raw clinical documentation into assessable portfolio evidence. Without it, assessors are left guessing what you want them to see.
The annotation does not have to be long. Two hundred to three hundred words is sufficient for most letters. It should answer four questions: what is the clinical context of this letter; what decision does it document and why was that decision consultant-level; which GMC domain and CiP does it most directly evidence; and what was the outcome (if you know). If you know the case was later discussed in an MDT or raised a safety issue that prompted a change in practice, note that too - it elevates a single letter into a richer evidence chain.
Write the annotation immediately after the clinic appointment, while the clinical context is fresh. A three-sentence note made the same week the letter was dictated is far more accurate and useful than a retrospective annotation written months later when you may not remember the diagnostic nuance or the patient's expressed preferences. Build this into your workflow now, even if your submission is still a year away.
Building a clinic letter portfolio: selection strategy
The selection task is more demanding than it looks. Most senior doctors have access to hundreds of clinic letters within the five-year window. The challenge is choosing the ones that collectively tell the right story about your practice, without cherry-picking cases that misrepresent your caseload or systematically excluding the kind of complexity that your specialism routinely requires.
A common selection error is gravitating toward letters about the most impressive-sounding cases. Unusual diagnoses or rare conditions may make the letter more interesting to read, but they do not necessarily make it stronger portfolio evidence. A letter documenting a nuanced decision about a common condition - whether to treat, when to investigate, how to communicate uncertainty to a patient - often evidences consultant-level practice more clearly than a letter about a rare case where the path forward was determined by a regional specialist centre rather than by your own clinical judgement.
The Capabilities in Practice (CiPs) in your specialty SSG are the correct selection grid. Read the CiPs relevant to your clinical work and ask: which of my clinic letters most directly demonstrates competence in this CiP? That question produces a better short-list than any instinctive ranking by "impressiveness".
How to prepare clinic letters for submission
Preparation has three components: anonymisation, annotation, and organisation. All three must be done before a letter enters the portfolio. Rushing any of them reduces the evidential value of the letter and, in the case of anonymisation, creates a patient safety and data protection risk.
Anonymise fully and accurately
Patient identifiable information includes: full name, date of birth, NHS number, home address, and hospital number. In some cases, highly specific details in the clinical narrative may also be re-identifying (for example, a very unusual combination of conditions, or a specific employer mentioned in the social history). Apply black redaction - not greying out or low-opacity overlays - to all identifiers. Your name and grade should remain in the letter. Where a letter was addressed to a named colleague, that name may also be removed unless it serves an evidential purpose.
Write the annotation immediately
The annotation is a brief document that accompanies the letter and tells the assessor what to look for. It should state the clinical context in one or two sentences, identify the specific GMC domain and CiP the letter evidences, explain the clinical decision or professional judgement the letter demonstrates, and note the outcome if known. Two hundred to three hundred words is the right length. The annotation should be written in plain English and should not attempt to rewrite the clinical content of the letter - it interprets, it does not substitute.
Pair with a CbD, reflective entry, or structured report where available
If the same case was the subject of a Case-based Discussion with your educational supervisor, note the cross-reference in the annotation. If you wrote a reflective entry about the same case, note that too. Cross-referencing strengthens both pieces of evidence: the letter provides the raw clinical documentation; the reflective entry provides the analytical frame. Together they demonstrate that you not only acted at consultant level but reflected on that action in a way that shows professional development and self-awareness.
Build the index
Once you have selected and annotated 10 to 20 letters, produce a one-page index. The index should list: the letter reference number, the date range (year and quarter is sufficient), the clinical category, the primary GMC domain, the relevant CiP from your SSG, and a one-line description of the key decision evidenced. This index is what the assessor uses to navigate your correspondence evidence. A clear, well-structured index signals a self-aware applicant who has done the domain-mapping work, not just printed out a stack of letters.
Do a final anonymisation check before upload
Redaction errors are easy to make, particularly with digital documents where the redacted content may still exist in a metadata layer. Before uploading to the GMC Online portal, open each PDF from the redacted version (not the original) and confirm that no patient identifiable information is visible. If you used image-based redaction, zoom in on the redacted areas to confirm the black overlays are complete. A patient data breach in a portfolio submission is a serious matter and could jeopardise your application beyond the immediate document issue.
What a well-annotated letter entry looks like
The mockup below illustrates a clinic letter formatted as a portfolio evidence entry, with colour-coded annotations showing which elements of the letter evidence which GMC domain. This represents a Geriatric Medicine outpatient review - a specialty where clinic letters are a particularly rich evidence source because they frequently capture multi-morbidity management, capacity considerations, and advance care planning.
Annotation (written by applicant - this appears before the letter)
Domain mapping: Primarily Domain 1 (CiP 1: Comprehensive geriatric assessment and management of frailty) and Domain 4 (CiP 7: Advance care planning and decision-making capacity). Secondary Domain 3 (communication with GP and community team).
Key decision: This letter documents the decision not to investigate further for a suspected malignancy in a frail patient with advanced dementia, following a goals-of-care conversation. The clinical judgement was that the investigation burden, risks of any intervention, and the patient's expressed wishes via their lasting power of attorney all pointed to a conservative, symptom-focused approach. This is a consultant-level decision that required weighing clinical evidence, ethical principles, and family communication simultaneously.
Outcome: Patient remained at home under community palliative care input for four months before dying peacefully in her own home, consistent with her expressed wishes. Cross-referenced to CbD entry [REF-CbD-047] and reflective entry [REF-R-019] in the Reflective Practice section.
Redacted clinic letter (patient identifiers removed)
The illustrative letter above is not unusual clinical content for a geriatric medicine consultant - decisions of this type are made frequently in that caseload. What makes it strong portfolio evidence is not the complexity of the clinical situation but the quality of the documentation: the reasoning is explicit, the process is documented, the communication trail is clear, and the annotation makes the evidential purpose immediately legible to an assessor.
Specialty-specific variations
Clinic letters are not equally useful across all specialties. Their value as portfolio evidence depends on the degree to which outpatient clinical reasoning is a core competency of the specialty, and on what the relevant SSG says about clinical documentation. Here is a brief overview of the specialties where clinic letter evidence tends to carry the most weight, and what to prioritise in each.
| Specialty | Most valuable letter types | Key domain focus |
|---|---|---|
| Neurology | Complex diagnostic letters (rare disease workup, atypical presentations), epilepsy management decisions, DVLA notification letters, capacity assessments | Domain 1 (diagnostic reasoning), Domain 4 (DVLA duty, capacity) |
| Geriatric Medicine | Comprehensive geriatric assessment letters, advance care planning documentation, capacity and best interests decisions, falls and frailty management, discharge coordination | All four domains, especially Domain 4 (ACP, capacity) |
| General Internal Medicine | Complex multi-system management letters, diagnostic uncertainty navigation, out-of-hours or acute-take follow-up correspondence | Domain 1 (clinical breadth), Domain 2 (safety-netting) |
| Rheumatology | Biologics initiation letters with risk-benefit documentation, complex connective tissue disease management, drug monitoring plans, shared decision-making on DMARDs | Domain 1 (guidelines), Domain 2 (drug safety, monitoring), Domain 3 (patient communication on risk) |
| Respiratory Medicine | Interstitial lung disease diagnostic workup letters, MDT coordination (ILD MDT, lung cancer MDT), CPAP/NIV initiation decisions, difficult oxygen prescribing | Domain 1 (diagnostic reasoning), Domain 3 (MDT coordination) |
| Gastroenterology | IBD flare management letters, surveillance colonoscopy decisions, complex polypharmacy in liver disease, transition letters for young adult IBD patients | Domain 1 (clinical reasoning), Domain 2 (surveillance and safety) |
| Dermatology | Complex inflammatory dermatosis management, systemic immunosuppressant initiation, patch testing interpretation, urgent 2WW referral decision rationale | Domain 1 (diagnostic reasoning), Domain 2 (cancer pathway) |
| Stroke Medicine | Post-stroke secondary prevention letters, DVLA notification documentation, family meetings following severe stroke, TIA risk stratification letters | Domain 1 (risk stratification), Domain 4 (DVLA, capacity in severe stroke) |
For procedural specialties where much of the consultant-level work happens in a theatre or procedure room rather than an outpatient clinic - for example, Interventional Radiology, Anaesthetics - clinic letters are less central to the evidence base. Pre-procedure assessment letters, consent documentation, and post-procedure follow-up letters can all contribute, but the primary evidence for these specialties lies in logbooks, procedure records, and WBAs. Do not try to force clinic letters into a portfolio where procedural logbook evidence is the natural backbone.
For laboratory specialties including Histopathology, Haematology, and Medical Microbiology, outpatient clinic letters may play a more limited role, though haematology consultants with a significant outpatient clinic component (particularly in non-malignant haematology) can and should include outpatient correspondence. For histopathology, the equivalent documentary evidence is the diagnostic report rather than the clinic letter.
Common mistakes assessors flag
Based on the common feedback patterns that educational supervisors and experienced applicants report from JRCPTB and Royal College assessments, these are the errors that most frequently undermine clinic letter evidence:
Submitting 40 to 60 unannotated letters is one of the most common errors. Assessors are not counting letters; they are evaluating the clinical thinking visible in the correspondence. A bulk submission signals that the applicant has not engaged with the selection task and has not done the domain-mapping work. It also increases the assessor's workload with no benefit to the applicant. Select 10 to 20, annotate all of them, and make the selection logic clear in your index.
A letter that records "investigations were arranged and a management plan was discussed" does not demonstrate consultant-level clinical reasoning. If your typical clinic letters are this sparse, you have two choices: start generating richer correspondence now (which has clinical governance benefits too), or pair sparse letters with CbD entries or reflective notes that supply the missing reasoning layer.
The date that matters is the date of the letter, not the date of submission. Letters from more than five years ago before your application date carry limited evidential weight. If you have excellent letters from six or seven years ago, you may reference them as contextual information but should not rely on them as core evidence. See the five-year rule article for the full guidance on recency requirements.
A partially redacted letter that allows re-identification of a patient creates a data protection risk and can jeopardise the whole submission. Check every letter before upload. Use black redaction throughout. If you are unsure whether a clinical detail is re-identifying in context, remove it or describe it in general terms in the annotation rather than including the identifiable detail in the submitted letter.
Including only your most complex or most successful cases creates a misleading picture of your practice. Assessors with clinical expertise will sometimes recognise if the case selection appears artificially skewed toward showpiece cases that do not reflect normal outpatient practice. Include a range of complexity - including cases that were straightforward and managed to guideline - alongside the more complex ones. Consistent quality across routine cases is itself a marker of consultant-level practice.
Pairing letters with other evidence types
Clinic letters work best as part of an evidence ecosystem, not as a standalone exhibit. The most effective approach is to identify your strongest cases and document them across multiple evidence types simultaneously: the letter as the primary clinical document; a CbD with your educational supervisor reviewing the same case; a reflective entry exploring what the case raised clinically or professionally; and, where appropriate, a brief structured report placing the case in the context of your developing consultant-level practice.
This triangulation approach is explicitly what assessors look for when evaluating whether an evidence base is real and contemporaneous, or assembled retrospectively from isolated documents. A CbD entry that references a specific clinic letter, which in turn references a reflective note about the same clinical question, creates a coherent narrative trail that is difficult to fabricate and carries significant evidential weight.
For your 5 to 8 most evidentially important cases: (1) the clinic letter as documentary evidence of the clinical action; (2) a CbD with your educational supervisor using the same case as the discussion focus; and (3) a reflective entry exploring the clinical reasoning and professional judgement the case required. Three pieces of evidence about the same case, from different angles, are worth ten isolated pieces of evidence about ten different cases.
For the structured report element of your application, clinic letters are excellent raw material. The structured report is written for the portfolio specifically and asks you to synthesise your clinical practice across a case or theme. A letter documenting a complex diagnosis, followed by a structured report explaining the diagnostic approach, the relevant literature, and what this case demonstrates about your competence in CiP X, is a model pairing that assessors find clear and credible.
Do not try to use clinic letters as a substitute for WBAs. The SSG for your specialty will set minimum WBA requirements. Clinic letters supplement WBA evidence; they do not replace it. An application that relies entirely on clinic letters with no WBAs is structurally incomplete regardless of how good the individual letters are.
If you are building evidence from a previous post as well as your current one, the evidence library article covers how to integrate correspondence from multiple posts into a coherent portfolio. The educational supervisor article covers how to brief your supervisor to make best use of clinic letters as CbD material.
Sources
Primary sources cited
| Source | Publisher | Relevance |
|---|---|---|
| Portfolio Pathway: applying for specialist registration | GMC | Core route guidance, domain framework, evidence requirements |
| Good Medical Practice 2024 | GMC | The four domain framework; professional standards underpinning the Portfolio Pathway assessment criteria |
| Guidance on evidence for the Portfolio Pathway | GMC | What types of evidence are appropriate; documentation standards; the five-year recency requirement |
| Portfolio Pathway (CESR) - evidence guidance | JRCPTB | Evidence standards for internal medicine specialties including Geriatric Medicine, GIM, Neurology, Respiratory, Rheumatology, Gastroenterology |
| Supporting information for revalidation | GMC | Guidance on clinical outcomes and case documentation that overlaps with Portfolio Pathway evidence requirements |
| Clinical correspondence and letters | BMA | Standards for clinical correspondence in NHS practice; relevant to the quality benchmark for letters used as portfolio evidence |
| Using patient data: guidance | ICO | Data protection context for redaction and use of patient correspondence in professional portfolios |
| Improved outcomes through better clinical correspondence | NHS England | NHS standards for clinical letter quality; what constitutes a clinically useful letter |
| Structured judgement review guidance | RCP London | The clinical judgement framework used by physician assessors; informs what assessors look for in clinical documentation |
Frequently asked questions
How many clinic letters should I include in a Portfolio Pathway submission?
There is no single number mandated across all specialties, but the working consensus among experienced applicants and educational supervisors is that 10 to 20 well-selected, annotated letters carry significantly more weight than 50 unannotated ones. The selection should demonstrate breadth rather than volume: different diagnostic categories, varying degrees of clinical complexity, different types of clinical decision (diagnostic workup, long-term management, escalation, de-escalation, palliative transition), and ideally different points in the patient journey. A portfolio that includes only straightforward new referral letters will be read as reflecting a clinic caseload rather than as evidence of consultant-level clinical reasoning. Assessors are trying to understand your decision-making, not count your correspondence output. Read your specialty SSG for any specific guidance on clinical correspondence or case documentation requirements, as some Royal Colleges are more prescriptive than others.
Do clinic letters need to be anonymised before submission?
Yes. Patient identifiable information must be removed or replaced before any clinical documentation is included in a Portfolio Pathway submission. The standard approach is to redact the patient's name, date of birth, NHS number, address, and any other direct identifiers using black redaction rather than greying out or blurring, which can sometimes be reversed digitally. The treating clinician's name and grade may remain as it is your evidence. Hospital number redaction is standard practice. If the letter was written to a named GP or colleague, their name may also be redacted unless it serves an evidential purpose. You do not need formal patient consent to include a redacted letter in your own professional portfolio, but you must ensure it cannot be used to re-identify the patient. Some Royal Colleges and deaneries have issued specific guidance on portfolio anonymisation; check your specialty SSG and any supplementary guidance from your relevant college before submission.
Can letters I wrote outside the five-year window count?
Evidence more than five years old carries limited weight in a Portfolio Pathway application, and correspondence from outside the window is generally not counted toward the core evidence requirements. The five-year rule applies to clinical documentation in the same way it applies to WBAs, case logs, and other evidence types. If you have a genuinely unusual or landmark case letter from outside the window, it may be worth including with an explicit acknowledgement of the date and an explanation of why the clinical reasoning it demonstrates remains current. However, this is a supplementary approach, not a substitute for current evidence. If your within-window correspondence is thin, the priority is generating new evidence from current practice rather than trying to rehabilitate old letters. See the article on the five-year rule and recent evidence for the full framework.
What is the difference between a clinic letter and a structured report for Portfolio Pathway purposes?
A clinic letter is correspondence generated in the ordinary course of clinical practice - typically a letter to the referring GP or to the patient following an outpatient appointment. It is primary clinical output that you produced as part of your job. A structured report, in the Portfolio Pathway context, is a document written retrospectively and specifically for the portfolio: it reflects on a case, maps your clinical reasoning to the GMC domains, describes the outcome, and explains what the case demonstrates about your practice. The two are complementary rather than interchangeable. A clinic letter provides the raw evidence - what you said, what you did, what you decided. The structured report provides the analytical layer - what this shows about your capabilities at consultant level. The most effective portfolio entries pair the two: the letter as exhibit, the structured report as the interpretive frame. Some Royal Colleges require a minimum number of structured reports; clinic letters alone rarely satisfy a structured report requirement.
Which GMC domains do clinic letters most directly evidence?
Clinic letters map primarily to Domain 1 (Knowledge, skills, and performance) through the clinical reasoning, diagnostic thinking, and management decisions visible in the letter; and to Domain 3 (Communication, partnership, and teamwork) through the quality of explanation to GPs and patients, multidisciplinary coordination, and shared decision-making documented in the correspondence. Domain 2 (Safety and quality) is evidenced through safety-netting, risk assessment, red-flag documentation, and escalation decisions visible in letters. Domain 4 (Maintaining trust) is harder to demonstrate through letters alone but is visible in letters documenting consent conversations, capacity assessments, advance care planning discussions, or handling of complaints and complex patient relationships. A well-curated letter portfolio should contain letters that contribute to all four domains, even if the distribution is uneven. Annotating each letter with an explicit domain mapping is one of the most useful things you can do before submission.
Can I use letters from a previous post in a different trust or region?
Yes, provided the letters fall within the five-year window and were written while you held an appropriate NHS post at a senior grade. Letters from locum, specialist grade, trust grade, or fixed-term Consultant posts are all eligible. Letters from posts outside the UK are subject to additional scrutiny: assessors will consider whether the clinical context is comparable to NHS practice, whether the standard of care described mirrors NHS expectations, and whether the decision-making shown is transferable to a UK consultant role. Letters from systems with significantly different referral pathways, formulary governance, or patient populations may require more detailed contextual annotation to help assessors situate the evidence. If your evidence base is predominantly from non-UK posts, consider prioritising UK-based correspondence where available and supplementing rather than leading with overseas letters. The article on translating overseas evidence covers the general framework in more detail.
Related specialism overviews
Clinic letter evidence is particularly relevant for these specialties. Each overview covers the full Portfolio Pathway route, SSG requirements, and evidence expectations for that specialty.